Company / Cash & Equivalents
INVO Fertility, Inc. Cash & Equivalents History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$5.7M
FY2021
5-year range
$5.7M / $5.7M
FY2017-FY2021
Trend
-43.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 6 years, ranging from $18,626 in FY2016 to $10M in FY2020.
Based on SEC 10-K filings.
$6M in FY2021 with a 5-year CAGR of +214.0%.
Improved from $212,243 to $6M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +504.3%
- 5-Year CAGR
- +214.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +214.0%, indicating consistent growth.
- In FY2021, cash & equivalents decreased 43.7% year-over-year.
- Peak cash & equivalents was recorded in FY2020.
- Lowest cash & equivalents in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $5.7M | -43.7% |
| FY2020 | $10.1M | +4657.6% |
| FY2019 | $212.2K | +724.0% |
| FY2018 | $25.8K | -83.1% |
| FY2017 | $152.4K | +718.2% |
| FY2016 | $18.6K | +0.0% |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026